For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of MGD Therapeutics as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment
- Sickle cell disease
- ß-Thalassemia
Companies Covered
- BioTheryX Therapeutics Inc.
- C4 Therapeutics Inc.
- Nurix Therapeutics Inc.
- Kymera Therapeutics Inc.
- Arvinas
- Inc.
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- BioTheryX Therapeutics Inc.
- C4 Therapeutics Inc.
- Nurix Therapeutics Inc.
- Kymera Therapeutics Inc.
- Arvinas
- Inc.
- Seed Therapeutics Inc.
- Monte Rosa Therapeutics Inc.

